Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center Hospital, 1007, Shimo-Nagakubo, Sunto-Nagaizumi, Shizuoka, 411-8777, Japan.
Division of Diagnostic Radiology, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
Surg Today. 2021 Sep;51(9):1429-1439. doi: 10.1007/s00595-021-02237-1. Epub 2021 Feb 9.
The aim of this study was to evaluate anatomical resection (AR) versus non-AR for primary solitary hepatocellular carcinoma (HCC) with predicted microscopic vessel invasion (MVI) and/or microscopic intrahepatic metastasis (MIM).
This retrospective study included 358 patients who underwent hepatectomy and had no evidence of MVI and/or MIM on preoperative imaging. The predictors of MVI and/or MIM were identified. The AR group (n = 222) and the non-AR group (n = 136) were classified by number of risk factor, and the survival rates were compared.
Microscopic vessel invasion and/or MIM were identified in 81 (22.6%) patients. A multivariate analysis showed that high des-gamma-carboxy prothrombin concentration [odds ratio (OR) 3.35], large tumor size (OR 3.16), and high aspartate aminotransferase concentration (OR 2.13) were significant predictors. The 5-year overall survival (OS) in the patients with zero, one, two, and three risk factors were 97.4%, 73.5%, 71.5%, and 65.5%, respectively. The OS of AR is superior to that of non-AR only in patients with one or two risk factors.
The present findings suggest that AR should be performed for patients with one or two risk factors, and that AR may prevent recurrence, as these patients are at risk of having MVI and/or MIM.
本研究旨在评估对于预测存在微血管侵犯(MVI)和/或微转移(MIM)的单发原发性肝细胞癌(HCC)患者,行解剖性肝切除术(AR)与非解剖性肝切除术(非 AR)的效果。
本回顾性研究纳入了 358 例行肝切除术且术前影像学检查未见 MVI 和/或 MIM 的患者。分析了 MVI 和/或 MIM 的预测因素。根据危险因素的数量将患者分为 AR 组(n=222)和非 AR 组(n=136),并比较了两组的生存率。
81 例(22.6%)患者存在 MVI 和/或 MIM。多因素分析显示,高 γ 羧基凝血酶原浓度[比值比(OR)3.35]、肿瘤较大[OR 3.16]和天门冬氨酸氨基转移酶浓度较高[OR 2.13]是显著的预测因素。无、1、2 和 3 个危险因素的患者 5 年总生存率(OS)分别为 97.4%、73.5%、71.5%和 65.5%。AR 的 OS 仅在存在 1 个或 2 个危险因素的患者中优于非 AR。
本研究结果提示,对于存在 1 个或 2 个危险因素的患者应行 AR,因为这些患者存在发生 MVI 和/或 MIM 的风险,AR 可能预防复发。